{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:03:05Z","timestamp":1781625785634,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To compare two blood glucose (BG) ranges in critically ill children with and without primary neurologic diagnoses in the Heart and Lung Failure\u2014Pediatric Insulin Titration trial (HALF-PINT; ClinicalTrials.gov Identifier NCT01565941).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Non-prespecified post hoc analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Thirty-one PICUs in the United States, and one in Canada.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Non-diabetic children enrolled from April 2012 to September 2016 with cardiovascular or respiratory failure and hyperglycemia. Patients in the neurologic subgroup had primary neurologic diagnoses on ICU admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>Patients were randomized to insulin infusion to target lower-BG (80\u2013110\u2009mg\/dL; 4.4\u20136.1 mmol\/L) or higher-BG (150\u2013180\u2009mg\/dL; 8.3\u201310 mmol\/L).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Primary diagnosis (neurologic vs. non-neurologic), daily BG and insulin values, outcomes (number of PICU-free days through day 28 and 1-y post-PICU discharge adaptive behavior composite score of Vineland Adaptive Behavior Scales, Second Edition). Of 698 patients analyzed, 64 (30 lower-BG target, 34 higher-BG target) had primary neurologic diagnoses and 634 (319 lower-BG target, 315 higher-BG target) had non-neurologic diagnoses. Within the neurologic subgroup, patients in the lower-BG targeting group had fewer ICU-free days compared with those in the higher-BG targeting group (median 8.5 vs. 21.1 d), whereas there was no difference between BG groups in the non-neurologic subgroup (20.5 vs. 19.3 d; interaction <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02). One-year adaptive behavior composite score was less favorable for the lower-BG targeting group in those with neurologic diagnoses (mean 63.3 vs. 87.6), but no different in those with non-neurologic diagnoses (81.9 vs. 78.4; interaction <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02). Lower-BG targeting was associated with more hypoglycemia (&lt; 60\u2009mg\/dL) in both diagnostic subgroups, with no differential effect across subgroups (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.47).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In this non-prespecified analysis of the HALF-PINT trial data, lower-BG targeting in hyperglycemic critically ill children with primary neurologic diagnoses was associated with unfavorable outcomes, while such BG targeting in those with non-neurologic diagnoses was not associated with adverse outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003689","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T15:00:11Z","timestamp":1738767611000},"page":"e432-e446","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Blood Glucose Range for Hyperglycemic PICU Children With Primary Neurologic Diagnoses: Analysis of the Heart and Lung Failure\u2014Pediatric Insulin Titration (HALF-PINT) Trial"],"prefix":"10.1097","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-4279","authenticated-orcid":false,"given":"Kerri L.","family":"LaRovere","sequence":"first","affiliation":[{"name":"Department of Neurology, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Asaro","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Coughlin-Wells","sequence":"additional","affiliation":[{"name":"Division of Medicine Critical Care, Department of Pediatrics, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay M.","family":"Nadkarni","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Children\u2019s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.D.","family":"Agus","sequence":"additional","affiliation":[{"name":"Division of Medicine Critical Care, Department of Pediatrics, Boston Children\u2019s Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Heart and Lung Failure\u2014Pediatric Insulin Titration (HALF-PINT) Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"R1-20250410","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PCC.0000000000002992","article-title":"The utilization of critical care resources in pediatric neurocritical care patients.","volume":"23","author":"DeSanti","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20250410","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00006123-200002000-00015","article-title":"The influence of hyperglycemia on neurological outcome in patients with severe head injury.","volume":"46","author":"Rovlias","year":"2000","journal-title":"Neurosurgery"},{"key":"R3-20250410","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.TA.0000135158.42242.B1","article-title":"The impact of hyperglycemia on patients with severe brain injury.","volume":"58","author":"Jeremitsky","year":"2005","journal-title":"J Trauma"},{"key":"R4-20250410","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients.","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20250410","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/01.WNL.0000158442.08857.FC","article-title":"Insulin therapy protects the central and peripheral nervous system of intensive care patients.","volume":"64","author":"van den Berghe","year":"2005","journal-title":"Neurology"},{"key":"R6-20250410","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients.","volume":"367","author":"Finfer","year":"2012","journal-title":"N Engl J Med"},{"key":"R7-20250410","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1302564","article-title":"A randomized trial of hyperglycemic control in pediatric intensive care.","volume":"370","author":"Macrae","year":"2014","journal-title":"N Engl J Med"},{"key":"R8-20250410","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMoa1612348","article-title":"Tight glycemic control in critically ill children.","volume":"376","author":"Agus","year":"2017","journal-title":"N Engl J Med"},{"key":"R9-20250410","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1097\/CCM.0000000000006174","article-title":"Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults 2024.","volume":"52","author":"Honarmand","year":"2024","journal-title":"Crit Care Med"},{"key":"R10-20250410","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"R11-20250410","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1161\/STR.0000000000000183","article-title":"Management of stroke in neonates and children: A scientific statement from the American Heart Association\/American Stroke Association.","volume":"50","author":"Ferriero","year":"2019","journal-title":"Stroke"},{"key":"R12-20250410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the guideline committee of the American Epilepsy Society.","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"R13-20250410","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status epilepticus: A comprehensive review by the American Epilepsy Society Treatments Committee.","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Curr"},{"key":"R14-20250410","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/PCC.0000000000001735","article-title":"Guidelines for the management of pediatric severe traumatic brain injury, third edition: Update of the Brain Trauma Foundation guidelines.","volume":"20","author":"Kochanek","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"R15-20250410","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1161\/CIR.0000000000000697","article-title":"Pediatric post-cardiac arrest care: A scientific statement from the American Heart Association.","volume":"140","author":"Topjian","year":"2019","journal-title":"Circulation"},{"key":"R16-20250410","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-038505D","article-title":"Part 4: Pediatric basic and advanced life support 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.","volume":"147","author":"Topjian","year":"2021","journal-title":"Pediatrics"},{"key":"R17-20250410","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpeds.2019.10.055","article-title":"Long-term neurobehavioral and quality of life outcomes of critically ill children after glycemic control.","volume":"218","author":"Biagas","year":"2020","journal-title":"J Pediatr"},{"key":"R18-20250410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cct.2016.12.023","article-title":"Design and rationale of Heart and Lung Failure\u2014Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children.","volume":"53","author":"Agus","year":"2017","journal-title":"Contemp Clin Trials"},{"key":"R20-20250410","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","article-title":"The PedsQL 4.0 as a pediatric population health measure: Feasibility, reliability, and validity.","volume":"3","author":"Varni","year":"2003","journal-title":"Ambul Pediatr"},{"key":"R21-20250410","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/pir.21.8.265","article-title":"The Child Behavior Checklist and related forms for assessing behavioral\/emotional problems and competencies.","volume":"21","author":"Achenbach","year":"2000","journal-title":"Pediatr Rev"},{"key":"R22-20250410","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1097\/00003246-200007000-00072","article-title":"Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments.","volume":"28","author":"Fiser","year":"2000","journal-title":"Crit Care Med"},{"key":"R23-20250410","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa0803725","article-title":"Early insulin therapy in very-low-birth-weight infants.","volume":"359","author":"Beardsall","year":"2008","journal-title":"N Engl J Med"},{"key":"R24-20250410","doi-asserted-by":"crossref","first-page":"e209378","DOI":"10.1212\/WNL.0000000000209378","article-title":"What is the role of lactate in brain metabolism, plasticity, and neurodegeneration?","volume":"102","author":"Benarroch","year":"2024","journal-title":"Neurology"},{"key":"R25-20250410","doi-asserted-by":"crossref","first-page":"13983","DOI":"10.1523\/JNEUROSCI.2040-10.2010","article-title":"The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy.","volume":"30","author":"Boumezbeur","year":"2010","journal-title":"J Neurosci"},{"key":"R26-20250410","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","article-title":"Glucose transporters in brain in health and disease.","volume":"472","author":"Koepsell","year":"2020","journal-title":"Pflugers Arch"},{"key":"R27-20250410","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1093\/brain\/awab255","article-title":"Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury.","volume":"144","author":"Hermanides","year":"2021","journal-title":"Brain"},{"key":"R28-20250410","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ACO.0000000000001183","article-title":"Cerebral metabolic derangements following traumatic brain injury.","volume":"35","author":"Demers-Marci","year":"2022","journal-title":"Curr Opin Anaesthesiol"},{"key":"R29-20250410","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3390\/ijms25052513","article-title":"Cerebral glucose metabolism following TBI: Changes in plasma glucose, glucose transport and alternative pathways of glycolysis\u2014a translational narrative review.","volume":"25","author":"Gribnau","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R30-20250410","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1378\/chest.07-2702","article-title":"Blood glucose control in critically ill adults and children: A survey on stated practice.","volume":"133","author":"Hirshberg","year":"2008","journal-title":"Chest"},{"key":"R31-20250410","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(09)60044-1","article-title":"Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study.","volume":"373","author":"Vlasselaers","year":"2009","journal-title":"Lancet"},{"key":"R32-20250410","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2012.12424","article-title":"Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: A randomized controlled trial.","volume":"308","author":"Mesotten","year":"2012","journal-title":"JAMA"},{"key":"R33-20250410","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2012.14151","article-title":"Pediatric critical care, glycemic control, and hypoglycemia: What is the real target?","volume":"308","author":"Tasker","year":"2012","journal-title":"JAMA"},{"key":"R34-20250410","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/PCC.0b013e3181e8f502","article-title":"Relationship between hypoglycemia and mortality in critically ill children.","volume":"11","author":"Faustino","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R35-20250410","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1111\/apa.12402","article-title":"Glycaemic threshold for activation of the stress response in children.","volume":"102","author":"Branco","year":"2013","journal-title":"Acta Paediatr"},{"key":"R36-20250410","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1411480","article-title":"Therapeutic hypothermia after out-of-hospital cardiac arrest in children.","volume":"372","author":"Moler","year":"2015","journal-title":"N Engl J Med"},{"key":"R37-20250410","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1610493","article-title":"Therapeutic hypothermia after in-hospital cardiac arrest in children.","volume":"376","author":"Moler","year":"2017","journal-title":"N Engl J Med"},{"key":"R38-20250410","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12028-021-01408-9","article-title":"Clinical characteristics and outcomes of children with acute catastrophic brain injury: A 13-year retrospective cohort study.","volume":"36","author":"LaRovere","year":"2022","journal-title":"Neurocrit Care"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:00:43Z","timestamp":1744290043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003689","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}